Pharmaceutical Considerations 



DIFFICULTIES here begin with the crude 

 drug. C. J. Zufall in a paper 1 asserts that 

 the pharmacopeial descriptions of aconite, 

 apocynum, belladonna leaves, berberis, buchu, cap- 

 sicum, cardamon, coca, colchicum seed, cubeb, ergot, 

 grindelia, lupulin, savin, scoparius, viburnum opulus 

 and viburnum prunifolium are more or less defective. 

 This paper is one of many bearing upon the same 

 problem, a matter of very considerable importance 

 and one that merits the most careful investigation. 

 The integrity of our botanic crudes is the founda- 

 tion of the success or failure of botanic remedies. 



Theoretically considered, the United States Phar- 

 macopeia products should be those of highest de- 

 velopment from the scientific and the clinical 

 standpoints, yet "New and Nonofficial Remedies," 

 1916 edition, lists and describes proprietary products 

 of the following botanic drugs: Various agar prepa- 

 rations, certain vegetable tar products, a few atropine 

 derivatives, chinosol, eucodin, stypticin, styptol, 

 several digitalis products, cymarin, ouabain, vari- 

 ous products of ergot, filmaron, aristol, several 

 ipecac products, E. bulgaricus and Kefir fungi 

 specialties, several carbohydrate medicinal foods, 

 coryfin, several opium principles and derivatives, 

 phloridzin, various pollen extracts, numerous quinine 

 derivatives, sandalwood oil derivatives, euscopol, 



l Jour. Amer. Pharmaceutical Ass'n, April, 1915. 

 1 33 



